News
“Ultrahuman Home is our step towards integrating environmental awareness into personal health. By continuously monitoring ...
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
A live audio webcast of the fireside chat presentation will be available at and an archived replay will be accessible in the Investors section of the Keros website at for up to 90 days following the ...
Fulcrum granted the new employee 70,000 options to purchase shares of the company’s common stock at an exercise price of $6.96 per share, the closing price per share of Fulcrum’s common stock as ...
The Inducement Grants have been granted pursuant to the Company’s 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into ...
The aforementioned inducement awards were approved by the compensation committee of the Company's board of directors in reliance on the employment inducement exception under Nasdaq Listing Rule 5635 ...
Arcutis is providing this information in accordance with Nasdaq Listing Rule 5635 (c) (4).
The stock options have an exercise price equal to $1.42 per share, the closing price of TELA Bio's common stock as reported on the Nasdaq Global Market on the Grant Date. The stock options have a ...
The inducement grants were approved by ORIC’s Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635 (c) (4), and were granted as a material inducement to employment in ...
Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate ...
The exercise price was DKK 224.40 per share for 4,163 of new shares and DKK 90.70 per share for 288,345 of new shares. The total proceeds to Zealand Pharma from the capital increase amount to DKK ...
Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug ...
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results